Definium Therapeutics Inc (DFTX)

Operating Expenses

$227.54M

TTM · Period ending: · USD

DFTX logo

DFTX Operating Expenses

Latest reported$227.54M
DFTX TTM Operating Expenses ($1.08M → $227.54M)
High-resolution chart · PNG

DFTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Definium Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
227,544,000
193,370,000
166,309,000
151,193,000
130,316,000
113,871,000
103,389,000
93,132,000
89,956,000
94,682,000
93,867,000
85,562,000
80,929,000
68,688,000
66,331,000
69,989,000
70,233,000
98,510,000
93,853,000
109,325,000
99,582,000
60,249,000
50,638,000
19,225,496
11,907,195
6,150,077
2,037,624
639,592
939,377
1,049,382
1,089,798
1,087,224
1,035,355
1,075,748
1,224,984
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.